Neuroone Medical Technologies (NMTC) Gross Profit Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 66.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.86% |
| Dec 31, 2025 | -18.63% |
| Sep 30, 2025 | 983.65% |
| Jun 30, 2025 | 224.56% |
| Mar 31, 2025 | 97.50% |
| Dec 31, 2024 | 623.54% |
| Sep 30, 2024 | -27.16% |
| Jun 30, 2024 | 15.68% |
| Mar 31, 2024 | 1,139.31% |
| Dec 31, 2023 | 2,263.92% |
| Sep 30, 2023 | 1,385.72% |
| Jun 30, 2023 | 3,899.56% |
| Mar 31, 2023 | 186.97% |
| Dec 31, 2022 | 6.02% |
| Sep 30, 2022 | 12.07% |
| Jun 30, 2022 | 70.64% |
| Mar 31, 2022 | -71.49% |
| Dec 31, 2021 | 65.22% |
| Jun 30, 2014 | -32.82% |
| Mar 31, 2014 | -59.36% |
| Dec 31, 2013 | -61.11% |
| Sep 30, 2013 | 995.65% |
| Jun 30, 2013 | 15.35% |
| Mar 31, 2013 | 176.19% |
| Dec 31, 2012 | 119.55% |
| Sep 30, 2012 | -97.17% |
| Jun 30, 2012 | -67.90% |
| Mar 31, 2012 | -95.21% |